Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049669

SVP & Chief Accounting Officer sold 2,648 shares at $19.32 ($51,159)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2017-08-16 Sale −2,648 $19.32 $51,159 50,838 D: show line 1 in the form
Open-market sales · 2,648 sh · avg $19.32 · $51,159
Loading xslF345X03/doc4.xml…